Publications by authors named "Tina Rodriguez"

Importance: The incidence of oral cavity cancer (OCC) is increasing among nonsmokers and young individuals without traditional risk factors worldwide. High sugar-sweetened beverage (SSB) intake is associated with various gastrointestinal cancers, but its association with OCC has not been explored.

Objective: To evaluate the association between SSB intake and the risk of OCC among smoking and nonsmoking women participating in the Nurses' Health Study (NHS) and Nurses' Health Study II (NHSII).

View Article and Find Full Text PDF
Article Synopsis
  • - The study examined the use of the modified pouchitis disease activity index (mPDAI) to assess symptoms and endoscopic findings among different pouchitis phenotypes in inflammatory bowel disease (IBD).
  • - A total of 103 IBD patients were analyzed, revealing that patients with normal pouches had a median mPDAI of 0, while those with cuffitis had the highest median score of 4.0, indicating more severe symptoms.
  • - The findings suggested that the mPDAI may have limited effectiveness in differentiating between various inflammatory phenotypes, prompting the need for further research to identify which symptoms should be monitored.
View Article and Find Full Text PDF

Background: Recent real-world effectiveness studies investigating tofacitinib have been encouraging. Questions remain regarding the long-term effectiveness and safety of tofacitinib, effect on endoscopic remission rates, histologic changes, and alterations in fecal calprotectin levels.

Methods: This retrospective study includes consecutive patients with inflammatory bowel disease (IBD) who initiated tofacitinib therapy.

View Article and Find Full Text PDF

Upadacitinib is a selective JAK-1 inhibitor approved for the treatment of rheumatoid arthritis and more recently, ulcerative colitis. Phase II trials demonstrated that upadacitinib induces endoscopic remission in patients with moderate-to-severe Crohn's disease. However, real-world data are lacking.

View Article and Find Full Text PDF

Background: Depression and anxiety are comorbidities of inflammatory bowel disease (IBD), and it is now recommended to screen IBD patients for these conditions. We screened patients using a novel computerized adaptive testing technology and compared the screening results to measures of disease activity.

Methods: Consecutive patients at our tertiary IBD clinic were asked to complete the validated CAT-MH™ survey (Adaptive Testing Technologies, Chicago, IL); we then reviewed disease and patient characteristics.

View Article and Find Full Text PDF

Depression and anxiety are comorbidities of inflammatory bowel disease (IBD). Though previous studies have proposed a relationship between anxiety, depression, and IBD, causality and directionality are largely unknown. Current and future research in these areas is aimed at exploring the biological underpinnings of this relationship, specifically pertaining to small molecule metabolism, such as tryptophan.

View Article and Find Full Text PDF